EBS - Emergent Biosolutions Q4 2022 Earnings Preview
- Emergent Biosolutions ( NYSE: EBS ) is scheduled to announce Q4 earnings results on Monday, February 27th, after market close.
- The consensus EPS Estimate is $0.07 (compared to $4.5 in year ago quarter) and the consensus Revenue Estimate is $291.27M (-59.7% Y/Y).
- Over the last 2 years, EBS has beaten EPS estimates 50% of the time and has beaten revenue estimates 38% of the time.
For further details see:
Emergent Biosolutions Q4 2022 Earnings Preview